JOURNAL OF MEDICINAL CHEMISTRY

JOURNAL OF MEDICINAL CHEMISTRY

J. Med. Chem.
影响因子:6.8
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:American Chemical Society
发刊时间:1959
发刊频率:Biweekly
收录数据库:SCIE/Scopus收录
ISSN:0022-2623

期刊介绍

The Journal of Medicinal Chemistry发表分子结构与生物活性或作用模式之间关系的相关研究。The Journal of Medicinal Chemistry publishes studies that contribute to an understanding of the relationship between molecular structure and biological activity or mode of action.Some specific areas that are appropriate include the following:Design, synthesis, and biological evaluation of novel biologically active compounds, diagnostic agents, or labeled ligands employed as pharmacological tools.Molecular modifications of reported series that lead to a significantly improved understanding of their structure-activity relationships (SAR). Routine extensions of existing series that do not utilize novel chemical or biological approaches or do not add significantly to a basic understanding of the SAR of the series will normally not be accepted for publication.Structural biological studies (X-ray, NMR, etc.) of relevant ligands and targets with the aim of investigating molecular recognition processes in the action of biologically active compounds.Molecular biological studies (e.g., site-directed mutagenesis) of macromolecular targets that lead to an improved understanding of molecular recognition.Computational studies that provide fresh insight into the SAR of compound series that are of current general interest or analysis of other available data that subsequently advance medicinal chemistry knowledge.Substantially novel computational chemistry methods with demonstrated value for the identification, optimization, or target interaction analysis of bioactive molecules.Effect of molecular structure on the distribution, pharmacokinetics, and metabolic transformation of biologically active compounds. This may include design, synthesis, and evaluation of novel types of prodrugs.Novel methodology with broad application to medicinal chemistry, but only if the methods have been tested on relevant molecules.
《药物化学杂志》发表的研究有助于理解分子结构和生物活性或作用模式之间的关系。一些适合的特定领域包括:*新型生物活性化合物、诊断剂或用作药理学工具的标记配体的设计、合成和生物学评价。*对报告系列进行分子修饰,从而显著改善对其构效关系(SAR)的理解。对现有系列的常规扩展,如果未使用新的化学或生物学方法,或未显著增加对系列SAR的基本理解,则通常不接受发表。*结构生物学研究(X射线、NMR等)目的是研究生物活性化合物作用中的分子识别过程。*分子生物学研究(如:定点诱变),这导致对分子识别的更好理解。*计算研究,为当前普遍感兴趣的化合物系列的SAR提供新的见解,或对随后推进药物化学知识的其他可用数据进行分析。*实质上新颖的计算化学方法,具有经证实的用于生物活性分子的鉴定、优化或靶相互作用分析的价值。*分子结构对生物活性化合物的分布、药代动力学和代谢转化的影响。这可能包括新型前药的设计、合成和评价。*广泛应用于药物化学的新方法,但前提是该方法已在相关分子上进行了测试。
年发文量 1179
国人发稿量 489.4
国人发文占比 0.42%
自引率 -
平均录取率0
平均审稿周期 平均2.1个月
版面费 -
偏重研究方向 医学-医药化学
期刊官网 https://pubs.acs.org/journal/jmcmar
投稿链接 https://acs.manuscriptcentral.com/acs

期刊高被引文献

Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER).
来源期刊:Journal of medicinal chemistryDOI:10.1021/ACS.JMEDCHEM.8B01572
Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01210
Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b00315
A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00723
Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01348
DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01403
3-[(1 S,2 S,3 R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00719
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00134
Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity
来源期刊:Journal of Medicinal ChemistryDOI:10.1021/acs.jmedchem.8b01947
Discovery and Optimization of Selective and in Vivo Active Inhibitors of the Lysophosphatidylserine Lipase α/β-Hydrolase Domain-Containing 12 (ABHD12).
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01958
Pharmacological Chaperones for the Treatment of α-Mannosidosis.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00153
De Novo Designed Amphipathic α-Helical Antimicrobial Peptides Incorporating Dab and Dap Residues on the Polar Face To Treat the Gram-Negative Pathogen, Acinetobacter baumannii.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01785
Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein-Ligand Complexes.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01925
Multistage Screening Reveals 3-substituted Indolin-2-one Derivatives as Novel and Isoform Selective c-Jun N-terminal kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00537
Environment-Sensitive Near-Infrared Probe for Fluorescent Discrimination of Aβ and Tau Fibrils in AD Brain.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00672
From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum towards Carbapenem-Resistant Bacteria.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00720
Novel Benzohydroxamate-based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis and Biological Evaluation.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01194
Virtual Screening Identifies Irreversible FMS-like Tyrosine Kinase 3 Inhibitors with Activity toward Resistance-Conferring Mutations.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01714
Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01540
(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR Kinase.
来源期刊:Journal of Medicinal ChemistryDOI:10.2210/PDB6OAC/PDB
Crown Ethers as Transthyretin Amyloidogenesis Inhibitors.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01700
Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00274
Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01573
Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01927
Synthesis and evaluation of novel TLR2 agonists as potential adjuvants for cancer vaccines.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01044
Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01862
Exposing Small-molecule Nano-entities By a Nuclear Magnetic Resonance Relaxation Assay.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00653
Development of Robust 17(R),18(S)-Epoxyeicosatetraenoic Acid (17,18-EEQ) Analogs as Potential Clinical Antiarrhythmic Agents.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00952
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b02021
Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate to Induce Apoptosis-Ferroptosis M2-TAMs Polarization for Combined Cancer Therapy.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00644
Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01891
Glucopyranosylidene-spiro-imidazolinones, a New Ring System: Synthesis and Evaluation as Glycogen Phosphorylase Inhibitors by Enzyme Kinetics and X-ray Crystallography.
来源期刊:Journal of Medicinal ChemistryDOI:10.2210/PDB6QA7/PDB
Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-based Design.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00891
A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01287
Sugar Kick Prevents Memory Impairment.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01668
In Silico Prediction of Hemolytic Toxicity on the Human Erythrocytes for Small Molecules by Machine-Learning and Genetic Algorithm.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00853
Rapid Metabolization of Protectin D1 by β-Oxidation of Its Polar Head Chain.
来源期刊:Journal of Medicinal ChemistryDOI:10.1021/ACS.JMEDCHEM.9B01463
Synthesis, Biological, and Structural Explorations of New Zwitterionic Derivatives of 14-O-Methyloxymorphone, as Potent μ/δ Opioid Agonists and Peripherally Selective Antinociceptives
来源期刊:Journal of Medicinal ChemistryDOI:10.1021/acs.jmedchem.8b01327
Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00351
Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00625
A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00673
Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AGRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00860
Design, Synthesis and Evaluation of 18F-labeled Monoacylglycerol Lipase Inhibitors as Novel Positron Emission Tomography Probes.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00936
Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01483
Targeting the Side-Chain Convergence of Hydrophobic α-Helical Hot Spots to Design Small-Molecule Mimetics: Key Binding Features for i, i + 3 and i + 7.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01324
Influence of non-natural cationic amino acids on the biological activity profile of innate defence regulator peptides.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01344
New Therapeutic Targets for Brain Function and Disease.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01947
Germacrane Sesquiterpenoids as a New Type of Anticardiac Fibrosis Agents Targeting Transforming Growth Factor β Type I Receptor (TβRI).
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b00708
SAR by 1D NMR.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.9b01688
Synthesis and Structural/Functional Characterization of Selective M14 Metallocarboxypeptidase Inhibitors Based on Phosphinic Pseudopeptide Scaffold: Implications on the Design of Specific Optical Probes.
来源期刊:Journal of medicinal chemistryDOI:10.1021/acs.jmedchem.8b01465

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
94.15%19.81%0.12%2.37%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
CHEMISTRY, MEDICINAL
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学1区
CHEMISTRY, MEDICINAL 药物化学
1区
2023年12月升级版
医学1区
CHEMISTRY, MEDICINAL 药物化学
1区
2022年12月旧的升级版
医学1区
CHEMISTRY, MEDICINAL 药物化学
1区